Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Alcresta Therapeutics

    Client Virtual Booth

    ALCRESTA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Alcresta Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Alcresta Therapeutics, Inc. One Newton Executive Park Suite 100 Newton, MA 02462
    Telephone
    Telephone
    + 617-431-3600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alcresta.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alcresta-therapeutics-inc./
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Linden Capital Partners Acquires Alcresta Therapeutics, Inc.
    Linden Capital Partners Acquires Alcresta Therapeutics, Inc.

    https://www.prnewswire.com/news-releases/linden-capital-partners-acquires-alcresta-therapeutics-inc-302086718.html

    PR NEWSWIRE
    12 Mar 2024
    Share Share
    Alcresta Announces Move to New Corporate Headquarters in Waltham, MA
    Alcresta Announces Move to New Corporate Headquarters in Waltham, MA

    https://www.prnewswire.com/news-releases/alcresta-therapeutics-announces-move-to-new-corporate-headquarters-in-waltham-ma-301694151.html

    PRNEWSWIRE
    05 Dec 2022
    Share Share
    Alcresta Therapeutics Announces Appointment of Chris Parrish as COO
    Alcresta Therapeutics Announces Appointment of Chris Parrish as COO

    https://www.prnewswire.com/news-releases/alcresta-therapeutics-announces-appointment-of-chris-parrish-as-chief-operations-officer-301430689.html

    PRNEWSWIRE
    29 Nov 2021
    Share Share
    Data from the ASSURE Study of Long-Term Use of RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE Published in Journal of Pediatric Gastroenterology and Nutrition
    Data from the ASSURE Study of Long-Term Use of RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE Published in Journal of Pediatric Gastroenterology and Nutrition

    http://www.alcresta.com/news/data-assure-study-long-term-use-relizorb%C2%AE-immobilized-lipase-cartridge-published-journal

    PRESS RELEASE
    02 Aug 2018
    Share Share
    Alcresta Announces RELiZORB® iMMOBILIZED LIPASE CARTRIDGE Issued (Q9994) by CMS
    Alcresta Announces RELiZORB® iMMOBILIZED LIPASE CARTRIDGE Issued (Q9994) by CMS

    https://www.biospace.com/article/releases/alcresta-therapeutics-announces-relizorb-immobilized-lipase-cartridge-has-been-issued-a-unique-q-code-q9994-by-cms/

    BIOSPACE
    19 Jun 2018
    Share Share
    Alcresta Presented Results at the North American Cystic F Conference-RELiZORB®
    Alcresta Presented Results at the North American Cystic F Conference-RELiZORB®

    https://www.businesswire.com/news/home/20171106005237/en/Alcresta-Therapeutics-Presented-Results-North-American-Cystic

    BUSINESSWIRE
    06 Nov 2017
    Share Share
    Alcresta Receives New Innovative Technology Contract from Vizient, For RELiZORB®
    Alcresta Receives New Innovative Technology Contract from Vizient, For RELiZORB®

    https://www.businesswire.com/news/home/20170919006528/en/Alcresta-Therapeutics-Receives-New-Innovative-Technology-Contract

    BUSINESSWIRE
    19 Sep 2017
    Share Share
    Alcresta Announces Positive Results, RELiZORB® Increased Fat Absorption
    Alcresta Announces Positive Results, RELiZORB® Increased Fat Absorption

    https://www.businesswire.com/news/home/20170731005332/en/Alcresta-Therapeutics-Announces-Positive-Results-RELiZORB%C2%AE-Increased

    BUSINESSWIRE
    31 Jul 2017
    Share Share
    Alcresta Therapeutics Receives 510(k) Clearance For Use of RELiZORB® in Children
    Alcresta Therapeutics Receives 510(k) Clearance For Use of RELiZORB® in Children

    https://www.businesswire.com/news/home/20170720005375/en/Alcresta-Therapeutics-Receives-510-Clearance-RELiZORB%C2%AE-Children

    BUSINESSWIRE
    20 Jul 2017
    Share Share
    Alcresta Therapeutics Inc.say raised about $10 million in equity financing
    Alcresta Therapeutics Inc.say raised about $10 million in equity financing

    https://www.bizjournals.com/boston/news/2012/04/17/alcresta-venture-capital.html

    BIZJOURNALS
    17 Apr 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search